GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sangamo Therapeutics Inc (STU:GBY) » Definitions » 6-1 Month Momentum %

Sangamo Therapeutics (STU:GBY) 6-1 Month Momentum % : 18.86% (As of Apr. 13, 2025)


View and export this data going back to . Start your Free Trial

What is Sangamo Therapeutics 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2025-04-13), Sangamo Therapeutics's 6-1 Month Momentum % is 18.86%.

The industry rank for Sangamo Therapeutics's 6-1 Month Momentum % or its related term are showing as below:

STU:GBY's 6-1 Month Momentum % is ranked better than
81.08% of 1469 companies
in the Biotechnology industry
Industry Median: -13.76 vs STU:GBY: 18.86

Competitive Comparison of Sangamo Therapeutics's 6-1 Month Momentum %

For the Biotechnology subindustry, Sangamo Therapeutics's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sangamo Therapeutics's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sangamo Therapeutics's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Sangamo Therapeutics's 6-1 Month Momentum % falls into.


;
;

Sangamo Therapeutics  (STU:GBY) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sangamo Therapeutics  (STU:GBY) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Sangamo Therapeutics 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Sangamo Therapeutics's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sangamo Therapeutics Business Description

Traded in Other Exchanges
Address
501 Canal Boulevard, Richmond, CA, USA, 94804
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Sangamo Therapeutics Headlines

No Headlines